nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Thrombocytopenia—Etoposide—sarcoma	0.000994	0.000997	CcSEcCtD
Goserelin—Tachycardia—Etoposide—sarcoma	0.000991	0.000994	CcSEcCtD
Goserelin—Abdominal pain—Vincristine—sarcoma	0.000991	0.000994	CcSEcCtD
Goserelin—Body temperature increased—Vincristine—sarcoma	0.000991	0.000994	CcSEcCtD
Goserelin—Skin disorder—Etoposide—sarcoma	0.000987	0.000989	CcSEcCtD
Goserelin—Dry skin—Doxorubicin—sarcoma	0.000982	0.000985	CcSEcCtD
Goserelin—Hyperhidrosis—Etoposide—sarcoma	0.000982	0.000984	CcSEcCtD
Goserelin—Angina pectoris—Epirubicin—sarcoma	0.000975	0.000978	CcSEcCtD
Goserelin—Urticaria—Mitoxantrone—sarcoma	0.00097	0.000972	CcSEcCtD
Goserelin—Breast disorder—Doxorubicin—sarcoma	0.000969	0.000971	CcSEcCtD
Goserelin—Anorexia—Etoposide—sarcoma	0.000968	0.00097	CcSEcCtD
Goserelin—Diarrhoea—Thiotepa—sarcoma	0.000967	0.00097	CcSEcCtD
Goserelin—Abdominal pain—Mitoxantrone—sarcoma	0.000965	0.000968	CcSEcCtD
Goserelin—Body temperature increased—Mitoxantrone—sarcoma	0.000965	0.000968	CcSEcCtD
Goserelin—Bronchitis—Epirubicin—sarcoma	0.000963	0.000965	CcSEcCtD
Goserelin—Diarrhoea—Dactinomycin—sarcoma	0.00096	0.000962	CcSEcCtD
Goserelin—Hypotension—Etoposide—sarcoma	0.000949	0.000951	CcSEcCtD
Goserelin—Dysuria—Epirubicin—sarcoma	0.000936	0.000938	CcSEcCtD
Goserelin—Dizziness—Thiotepa—sarcoma	0.000935	0.000937	CcSEcCtD
Goserelin—Upper respiratory tract infection—Epirubicin—sarcoma	0.000931	0.000933	CcSEcCtD
Goserelin—Influenza—Doxorubicin—sarcoma	0.000926	0.000929	CcSEcCtD
Goserelin—Pollakiuria—Epirubicin—sarcoma	0.000925	0.000927	CcSEcCtD
Goserelin—Hypersensitivity—Vincristine—sarcoma	0.000924	0.000926	CcSEcCtD
Goserelin—Photosensitivity reaction—Epirubicin—sarcoma	0.000914	0.000916	CcSEcCtD
Goserelin—Paraesthesia—Etoposide—sarcoma	0.000912	0.000914	CcSEcCtD
Goserelin—Weight increased—Epirubicin—sarcoma	0.000911	0.000913	CcSEcCtD
Goserelin—Dyspnoea—Etoposide—sarcoma	0.000906	0.000908	CcSEcCtD
Goserelin—Hyperglycaemia—Epirubicin—sarcoma	0.000903	0.000905	CcSEcCtD
Goserelin—Somnolence—Etoposide—sarcoma	0.000903	0.000905	CcSEcCtD
Goserelin—Angina pectoris—Doxorubicin—sarcoma	0.000902	0.000905	CcSEcCtD
Goserelin—Hypersensitivity—Mitoxantrone—sarcoma	0.0009	0.000902	CcSEcCtD
Goserelin—Asthenia—Vincristine—sarcoma	0.0009	0.000902	CcSEcCtD
Goserelin—Vomiting—Thiotepa—sarcoma	0.000899	0.000901	CcSEcCtD
Goserelin—Pneumonia—Epirubicin—sarcoma	0.000898	0.0009	CcSEcCtD
Goserelin—Drowsiness—Epirubicin—sarcoma	0.000893	0.000895	CcSEcCtD
Goserelin—Vomiting—Dactinomycin—sarcoma	0.000892	0.000894	CcSEcCtD
Goserelin—Rash—Thiotepa—sarcoma	0.000892	0.000894	CcSEcCtD
Goserelin—Bronchitis—Doxorubicin—sarcoma	0.000891	0.000893	CcSEcCtD
Goserelin—Dermatitis—Thiotepa—sarcoma	0.000891	0.000893	CcSEcCtD
Goserelin—Headache—Thiotepa—sarcoma	0.000886	0.000888	CcSEcCtD
Goserelin—Rash—Dactinomycin—sarcoma	0.000885	0.000887	CcSEcCtD
Goserelin—Decreased appetite—Etoposide—sarcoma	0.000883	0.000885	CcSEcCtD
Goserelin—Renal failure—Epirubicin—sarcoma	0.000878	0.00088	CcSEcCtD
Goserelin—Asthenia—Mitoxantrone—sarcoma	0.000876	0.000878	CcSEcCtD
Goserelin—Fatigue—Etoposide—sarcoma	0.000876	0.000878	CcSEcCtD
Goserelin—Jaundice—Epirubicin—sarcoma	0.00087	0.000872	CcSEcCtD
Goserelin—Pain—Etoposide—sarcoma	0.000869	0.000871	CcSEcCtD
Goserelin—Constipation—Etoposide—sarcoma	0.000869	0.000871	CcSEcCtD
Goserelin—Urinary tract infection—Epirubicin—sarcoma	0.000868	0.00087	CcSEcCtD
Goserelin—Dysuria—Doxorubicin—sarcoma	0.000866	0.000868	CcSEcCtD
Goserelin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000861	0.000863	CcSEcCtD
Goserelin—Diarrhoea—Vincristine—sarcoma	0.000858	0.00086	CcSEcCtD
Goserelin—Sweating—Epirubicin—sarcoma	0.000856	0.000858	CcSEcCtD
Goserelin—Pollakiuria—Doxorubicin—sarcoma	0.000856	0.000858	CcSEcCtD
Goserelin—Haematuria—Epirubicin—sarcoma	0.000851	0.000853	CcSEcCtD
Goserelin—Photosensitivity reaction—Doxorubicin—sarcoma	0.000846	0.000848	CcSEcCtD
Goserelin—Weight increased—Doxorubicin—sarcoma	0.000843	0.000845	CcSEcCtD
Goserelin—Epistaxis—Epirubicin—sarcoma	0.000842	0.000844	CcSEcCtD
Goserelin—Nausea—Thiotepa—sarcoma	0.00084	0.000842	CcSEcCtD
Goserelin—Sinusitis—Epirubicin—sarcoma	0.000838	0.00084	CcSEcCtD
Goserelin—Feeling abnormal—Etoposide—sarcoma	0.000837	0.000839	CcSEcCtD
Goserelin—Hyperglycaemia—Doxorubicin—sarcoma	0.000836	0.000838	CcSEcCtD
Goserelin—Diarrhoea—Mitoxantrone—sarcoma	0.000835	0.000837	CcSEcCtD
Goserelin—Nausea—Dactinomycin—sarcoma	0.000834	0.000836	CcSEcCtD
Goserelin—Pneumonia—Doxorubicin—sarcoma	0.000831	0.000833	CcSEcCtD
Goserelin—Gastrointestinal pain—Etoposide—sarcoma	0.000831	0.000833	CcSEcCtD
Goserelin—Dizziness—Vincristine—sarcoma	0.000829	0.000831	CcSEcCtD
Goserelin—Drowsiness—Doxorubicin—sarcoma	0.000826	0.000828	CcSEcCtD
Goserelin—LHCGR—Ovarian Infertility Genes—GJA4—sarcoma	0.00082	0.344	CbGpPWpGaD
Goserelin—Renal failure—Doxorubicin—sarcoma	0.000812	0.000814	CcSEcCtD
Goserelin—Urticaria—Etoposide—sarcoma	0.000807	0.000809	CcSEcCtD
Goserelin—Haemoglobin—Epirubicin—sarcoma	0.000805	0.000807	CcSEcCtD
Goserelin—Jaundice—Doxorubicin—sarcoma	0.000805	0.000807	CcSEcCtD
Goserelin—Rhinitis—Epirubicin—sarcoma	0.000803	0.000805	CcSEcCtD
Goserelin—Abdominal pain—Etoposide—sarcoma	0.000803	0.000805	CcSEcCtD
Goserelin—Body temperature increased—Etoposide—sarcoma	0.000803	0.000805	CcSEcCtD
Goserelin—Urinary tract infection—Doxorubicin—sarcoma	0.000803	0.000805	CcSEcCtD
Goserelin—Haemorrhage—Epirubicin—sarcoma	0.000801	0.000803	CcSEcCtD
Goserelin—Hepatitis—Epirubicin—sarcoma	0.000801	0.000803	CcSEcCtD
Goserelin—Vomiting—Vincristine—sarcoma	0.000797	0.000799	CcSEcCtD
Goserelin—Pharyngitis—Epirubicin—sarcoma	0.000795	0.000797	CcSEcCtD
Goserelin—Sweating—Doxorubicin—sarcoma	0.000792	0.000794	CcSEcCtD
Goserelin—Urinary tract disorder—Epirubicin—sarcoma	0.000791	0.000793	CcSEcCtD
Goserelin—Rash—Vincristine—sarcoma	0.000791	0.000792	CcSEcCtD
Goserelin—Dermatitis—Vincristine—sarcoma	0.00079	0.000792	CcSEcCtD
Goserelin—Oedema peripheral—Epirubicin—sarcoma	0.000789	0.000791	CcSEcCtD
Goserelin—Haematuria—Doxorubicin—sarcoma	0.000788	0.000789	CcSEcCtD
Goserelin—Urethral disorder—Epirubicin—sarcoma	0.000786	0.000787	CcSEcCtD
Goserelin—Headache—Vincristine—sarcoma	0.000785	0.000787	CcSEcCtD
Goserelin—Epistaxis—Doxorubicin—sarcoma	0.000779	0.000781	CcSEcCtD
Goserelin—Vomiting—Mitoxantrone—sarcoma	0.000776	0.000778	CcSEcCtD
Goserelin—Sinusitis—Doxorubicin—sarcoma	0.000775	0.000777	CcSEcCtD
Goserelin—Rash—Mitoxantrone—sarcoma	0.00077	0.000772	CcSEcCtD
Goserelin—Dermatitis—Mitoxantrone—sarcoma	0.000769	0.000771	CcSEcCtD
Goserelin—Headache—Mitoxantrone—sarcoma	0.000765	0.000767	CcSEcCtD
Goserelin—Eye disorder—Epirubicin—sarcoma	0.000749	0.000751	CcSEcCtD
Goserelin—Hypersensitivity—Etoposide—sarcoma	0.000748	0.00075	CcSEcCtD
Goserelin—Haemoglobin—Doxorubicin—sarcoma	0.000745	0.000747	CcSEcCtD
Goserelin—Nausea—Vincristine—sarcoma	0.000745	0.000747	CcSEcCtD
Goserelin—Cardiac disorder—Epirubicin—sarcoma	0.000744	0.000746	CcSEcCtD
Goserelin—Rhinitis—Doxorubicin—sarcoma	0.000743	0.000745	CcSEcCtD
Goserelin—Haemorrhage—Doxorubicin—sarcoma	0.000742	0.000743	CcSEcCtD
Goserelin—Hepatitis—Doxorubicin—sarcoma	0.000742	0.000743	CcSEcCtD
Goserelin—Pharyngitis—Doxorubicin—sarcoma	0.000736	0.000738	CcSEcCtD
Goserelin—Urinary tract disorder—Doxorubicin—sarcoma	0.000732	0.000734	CcSEcCtD
Goserelin—Oedema peripheral—Doxorubicin—sarcoma	0.00073	0.000732	CcSEcCtD
Goserelin—Asthenia—Etoposide—sarcoma	0.000729	0.00073	CcSEcCtD
Goserelin—Angiopathy—Epirubicin—sarcoma	0.000727	0.000729	CcSEcCtD
Goserelin—Urethral disorder—Doxorubicin—sarcoma	0.000727	0.000729	CcSEcCtD
Goserelin—Nausea—Mitoxantrone—sarcoma	0.000725	0.000727	CcSEcCtD
Goserelin—Immune system disorder—Epirubicin—sarcoma	0.000724	0.000726	CcSEcCtD
Goserelin—Chills—Epirubicin—sarcoma	0.000719	0.000721	CcSEcCtD
Goserelin—Pruritus—Etoposide—sarcoma	0.000719	0.00072	CcSEcCtD
Goserelin—Arrhythmia—Epirubicin—sarcoma	0.000716	0.000718	CcSEcCtD
Goserelin—Alopecia—Epirubicin—sarcoma	0.000708	0.00071	CcSEcCtD
Goserelin—Mental disorder—Epirubicin—sarcoma	0.000702	0.000704	CcSEcCtD
Goserelin—Erythema—Epirubicin—sarcoma	0.000698	0.000699	CcSEcCtD
Goserelin—Malnutrition—Epirubicin—sarcoma	0.000698	0.000699	CcSEcCtD
Goserelin—Diarrhoea—Etoposide—sarcoma	0.000695	0.000697	CcSEcCtD
Goserelin—Eye disorder—Doxorubicin—sarcoma	0.000693	0.000695	CcSEcCtD
Goserelin—Cardiac disorder—Doxorubicin—sarcoma	0.000688	0.00069	CcSEcCtD
Goserelin—Flatulence—Epirubicin—sarcoma	0.000687	0.000689	CcSEcCtD
Goserelin—Tension—Epirubicin—sarcoma	0.000685	0.000686	CcSEcCtD
Goserelin—Nervousness—Epirubicin—sarcoma	0.000678	0.000679	CcSEcCtD
Goserelin—Back pain—Epirubicin—sarcoma	0.000675	0.000676	CcSEcCtD
Goserelin—Angiopathy—Doxorubicin—sarcoma	0.000673	0.000674	CcSEcCtD
Goserelin—Dizziness—Etoposide—sarcoma	0.000672	0.000673	CcSEcCtD
Goserelin—Muscle spasms—Epirubicin—sarcoma	0.000671	0.000672	CcSEcCtD
Goserelin—Immune system disorder—Doxorubicin—sarcoma	0.00067	0.000671	CcSEcCtD
Goserelin—Chills—Doxorubicin—sarcoma	0.000665	0.000667	CcSEcCtD
Goserelin—Arrhythmia—Doxorubicin—sarcoma	0.000662	0.000664	CcSEcCtD
Goserelin—Vision blurred—Epirubicin—sarcoma	0.000657	0.000659	CcSEcCtD
Goserelin—Alopecia—Doxorubicin—sarcoma	0.000655	0.000657	CcSEcCtD
Goserelin—Mental disorder—Doxorubicin—sarcoma	0.00065	0.000651	CcSEcCtD
Goserelin—Ill-defined disorder—Epirubicin—sarcoma	0.000647	0.000649	CcSEcCtD
Goserelin—Vomiting—Etoposide—sarcoma	0.000646	0.000647	CcSEcCtD
Goserelin—Erythema—Doxorubicin—sarcoma	0.000645	0.000647	CcSEcCtD
Goserelin—Malnutrition—Doxorubicin—sarcoma	0.000645	0.000647	CcSEcCtD
Goserelin—Anaemia—Epirubicin—sarcoma	0.000645	0.000646	CcSEcCtD
Goserelin—Rash—Etoposide—sarcoma	0.00064	0.000642	CcSEcCtD
Goserelin—Dermatitis—Etoposide—sarcoma	0.00064	0.000641	CcSEcCtD
Goserelin—Headache—Etoposide—sarcoma	0.000636	0.000638	CcSEcCtD
Goserelin—Flatulence—Doxorubicin—sarcoma	0.000636	0.000638	CcSEcCtD
Goserelin—Tension—Doxorubicin—sarcoma	0.000633	0.000635	CcSEcCtD
Goserelin—Malaise—Epirubicin—sarcoma	0.000629	0.000631	CcSEcCtD
Goserelin—Nervousness—Doxorubicin—sarcoma	0.000627	0.000628	CcSEcCtD
Goserelin—Leukopenia—Epirubicin—sarcoma	0.000624	0.000626	CcSEcCtD
Goserelin—Back pain—Doxorubicin—sarcoma	0.000624	0.000626	CcSEcCtD
Goserelin—Muscle spasms—Doxorubicin—sarcoma	0.000621	0.000622	CcSEcCtD
Goserelin—Palpitations—Epirubicin—sarcoma	0.000616	0.000618	CcSEcCtD
Goserelin—Cough—Epirubicin—sarcoma	0.000609	0.00061	CcSEcCtD
Goserelin—Vision blurred—Doxorubicin—sarcoma	0.000608	0.00061	CcSEcCtD
Goserelin—Convulsion—Epirubicin—sarcoma	0.000604	0.000606	CcSEcCtD
Goserelin—Nausea—Etoposide—sarcoma	0.000603	0.000605	CcSEcCtD
Goserelin—Hypertension—Epirubicin—sarcoma	0.000602	0.000604	CcSEcCtD
Goserelin—Ill-defined disorder—Doxorubicin—sarcoma	0.000599	0.0006	CcSEcCtD
Goserelin—Anaemia—Doxorubicin—sarcoma	0.000597	0.000598	CcSEcCtD
Goserelin—Myalgia—Epirubicin—sarcoma	0.000594	0.000595	CcSEcCtD
Goserelin—Chest pain—Epirubicin—sarcoma	0.000594	0.000595	CcSEcCtD
Goserelin—Arthralgia—Epirubicin—sarcoma	0.000594	0.000595	CcSEcCtD
Goserelin—Anxiety—Epirubicin—sarcoma	0.000592	0.000593	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00059	0.000591	CcSEcCtD
Goserelin—Discomfort—Epirubicin—sarcoma	0.000587	0.000588	CcSEcCtD
Goserelin—Malaise—Doxorubicin—sarcoma	0.000582	0.000583	CcSEcCtD
Goserelin—Dry mouth—Epirubicin—sarcoma	0.000581	0.000582	CcSEcCtD
Goserelin—Leukopenia—Doxorubicin—sarcoma	0.000578	0.000579	CcSEcCtD
Goserelin—Confusional state—Epirubicin—sarcoma	0.000574	0.000575	CcSEcCtD
Goserelin—Palpitations—Doxorubicin—sarcoma	0.00057	0.000572	CcSEcCtD
Goserelin—Anaphylactic shock—Epirubicin—sarcoma	0.000569	0.000571	CcSEcCtD
Goserelin—Oedema—Epirubicin—sarcoma	0.000569	0.000571	CcSEcCtD
Goserelin—Infection—Epirubicin—sarcoma	0.000566	0.000567	CcSEcCtD
Goserelin—Cough—Doxorubicin—sarcoma	0.000563	0.000565	CcSEcCtD
Goserelin—Shock—Epirubicin—sarcoma	0.00056	0.000561	CcSEcCtD
Goserelin—Convulsion—Doxorubicin—sarcoma	0.000559	0.000561	CcSEcCtD
Goserelin—Nervous system disorder—Epirubicin—sarcoma	0.000558	0.00056	CcSEcCtD
Goserelin—Thrombocytopenia—Epirubicin—sarcoma	0.000557	0.000559	CcSEcCtD
Goserelin—Hypertension—Doxorubicin—sarcoma	0.000557	0.000559	CcSEcCtD
Goserelin—Tachycardia—Epirubicin—sarcoma	0.000556	0.000557	CcSEcCtD
Goserelin—Skin disorder—Epirubicin—sarcoma	0.000553	0.000554	CcSEcCtD
Goserelin—Hyperhidrosis—Epirubicin—sarcoma	0.00055	0.000552	CcSEcCtD
Goserelin—Chest pain—Doxorubicin—sarcoma	0.00055	0.000551	CcSEcCtD
Goserelin—Myalgia—Doxorubicin—sarcoma	0.00055	0.000551	CcSEcCtD
Goserelin—Arthralgia—Doxorubicin—sarcoma	0.00055	0.000551	CcSEcCtD
Goserelin—Anxiety—Doxorubicin—sarcoma	0.000548	0.000549	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000546	0.000547	CcSEcCtD
Goserelin—Discomfort—Doxorubicin—sarcoma	0.000543	0.000544	CcSEcCtD
Goserelin—Anorexia—Epirubicin—sarcoma	0.000543	0.000544	CcSEcCtD
Goserelin—Dry mouth—Doxorubicin—sarcoma	0.000537	0.000539	CcSEcCtD
Goserelin—Hypotension—Epirubicin—sarcoma	0.000532	0.000533	CcSEcCtD
Goserelin—Confusional state—Doxorubicin—sarcoma	0.000531	0.000532	CcSEcCtD
Goserelin—Anaphylactic shock—Doxorubicin—sarcoma	0.000527	0.000528	CcSEcCtD
Goserelin—Oedema—Doxorubicin—sarcoma	0.000527	0.000528	CcSEcCtD
Goserelin—Infection—Doxorubicin—sarcoma	0.000523	0.000525	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000519	0.00052	CcSEcCtD
Goserelin—Shock—Doxorubicin—sarcoma	0.000518	0.00052	CcSEcCtD
Goserelin—Nervous system disorder—Doxorubicin—sarcoma	0.000517	0.000518	CcSEcCtD
Goserelin—Thrombocytopenia—Doxorubicin—sarcoma	0.000516	0.000517	CcSEcCtD
Goserelin—Insomnia—Epirubicin—sarcoma	0.000515	0.000516	CcSEcCtD
Goserelin—Tachycardia—Doxorubicin—sarcoma	0.000514	0.000515	CcSEcCtD
Goserelin—Skin disorder—Doxorubicin—sarcoma	0.000512	0.000513	CcSEcCtD
Goserelin—Paraesthesia—Epirubicin—sarcoma	0.000511	0.000512	CcSEcCtD
Goserelin—Hyperhidrosis—Doxorubicin—sarcoma	0.000509	0.00051	CcSEcCtD
Goserelin—Dyspnoea—Epirubicin—sarcoma	0.000508	0.000509	CcSEcCtD
Goserelin—Somnolence—Epirubicin—sarcoma	0.000506	0.000507	CcSEcCtD
Goserelin—Anorexia—Doxorubicin—sarcoma	0.000502	0.000503	CcSEcCtD
Goserelin—Dyspepsia—Epirubicin—sarcoma	0.000501	0.000502	CcSEcCtD
Goserelin—Decreased appetite—Epirubicin—sarcoma	0.000495	0.000496	CcSEcCtD
Goserelin—Hypotension—Doxorubicin—sarcoma	0.000492	0.000493	CcSEcCtD
Goserelin—Fatigue—Epirubicin—sarcoma	0.000491	0.000492	CcSEcCtD
Goserelin—Constipation—Epirubicin—sarcoma	0.000487	0.000488	CcSEcCtD
Goserelin—Pain—Epirubicin—sarcoma	0.000487	0.000488	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00048	0.000481	CcSEcCtD
Goserelin—Insomnia—Doxorubicin—sarcoma	0.000476	0.000478	CcSEcCtD
Goserelin—Paraesthesia—Doxorubicin—sarcoma	0.000473	0.000474	CcSEcCtD
Goserelin—Dyspnoea—Doxorubicin—sarcoma	0.00047	0.000471	CcSEcCtD
Goserelin—Feeling abnormal—Epirubicin—sarcoma	0.000469	0.00047	CcSEcCtD
Goserelin—Somnolence—Doxorubicin—sarcoma	0.000468	0.000469	CcSEcCtD
Goserelin—Gastrointestinal pain—Epirubicin—sarcoma	0.000466	0.000467	CcSEcCtD
Goserelin—Dyspepsia—Doxorubicin—sarcoma	0.000464	0.000465	CcSEcCtD
Goserelin—Decreased appetite—Doxorubicin—sarcoma	0.000458	0.000459	CcSEcCtD
Goserelin—Fatigue—Doxorubicin—sarcoma	0.000454	0.000455	CcSEcCtD
Goserelin—Urticaria—Epirubicin—sarcoma	0.000452	0.000453	CcSEcCtD
Goserelin—Pain—Doxorubicin—sarcoma	0.00045	0.000452	CcSEcCtD
Goserelin—Constipation—Doxorubicin—sarcoma	0.00045	0.000452	CcSEcCtD
Goserelin—Abdominal pain—Epirubicin—sarcoma	0.00045	0.000451	CcSEcCtD
Goserelin—Body temperature increased—Epirubicin—sarcoma	0.00045	0.000451	CcSEcCtD
Goserelin—Feeling abnormal—Doxorubicin—sarcoma	0.000434	0.000435	CcSEcCtD
Goserelin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000431	0.000432	CcSEcCtD
Goserelin—Hypersensitivity—Epirubicin—sarcoma	0.000419	0.00042	CcSEcCtD
Goserelin—Urticaria—Doxorubicin—sarcoma	0.000419	0.00042	CcSEcCtD
Goserelin—Body temperature increased—Doxorubicin—sarcoma	0.000416	0.000417	CcSEcCtD
Goserelin—Abdominal pain—Doxorubicin—sarcoma	0.000416	0.000417	CcSEcCtD
Goserelin—Asthenia—Epirubicin—sarcoma	0.000408	0.000409	CcSEcCtD
Goserelin—Pruritus—Epirubicin—sarcoma	0.000403	0.000404	CcSEcCtD
Goserelin—Diarrhoea—Epirubicin—sarcoma	0.00039	0.00039	CcSEcCtD
Goserelin—Hypersensitivity—Doxorubicin—sarcoma	0.000388	0.000389	CcSEcCtD
Goserelin—Asthenia—Doxorubicin—sarcoma	0.000378	0.000379	CcSEcCtD
Goserelin—Dizziness—Epirubicin—sarcoma	0.000376	0.000377	CcSEcCtD
Goserelin—Pruritus—Doxorubicin—sarcoma	0.000373	0.000374	CcSEcCtD
Goserelin—Vomiting—Epirubicin—sarcoma	0.000362	0.000363	CcSEcCtD
Goserelin—Diarrhoea—Doxorubicin—sarcoma	0.00036	0.000361	CcSEcCtD
Goserelin—Rash—Epirubicin—sarcoma	0.000359	0.00036	CcSEcCtD
Goserelin—Dermatitis—Epirubicin—sarcoma	0.000359	0.00036	CcSEcCtD
Goserelin—Headache—Epirubicin—sarcoma	0.000357	0.000358	CcSEcCtD
Goserelin—Dizziness—Doxorubicin—sarcoma	0.000348	0.000349	CcSEcCtD
Goserelin—Nausea—Epirubicin—sarcoma	0.000338	0.000339	CcSEcCtD
Goserelin—Vomiting—Doxorubicin—sarcoma	0.000335	0.000336	CcSEcCtD
Goserelin—Rash—Doxorubicin—sarcoma	0.000332	0.000333	CcSEcCtD
Goserelin—Dermatitis—Doxorubicin—sarcoma	0.000332	0.000333	CcSEcCtD
Goserelin—Headache—Doxorubicin—sarcoma	0.00033	0.000331	CcSEcCtD
Goserelin—Nausea—Doxorubicin—sarcoma	0.000313	0.000314	CcSEcCtD
Goserelin—LHCGR—Peptide GPCRs—CXCR4—sarcoma	0.000207	0.087	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CXCR4—sarcoma	0.000139	0.0582	CbGpPWpGaD
Goserelin—LHCGR—Arf6 signaling events—SRC—sarcoma	0.00013	0.0547	CbGpPWpGaD
Goserelin—LHCGR—Arf6 signaling events—EGFR—sarcoma	0.000114	0.048	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	7.62e-05	0.032	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	6.53e-05	0.0274	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCR4—sarcoma	4.97e-05	0.0209	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	4.37e-05	0.0184	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCR4—sarcoma	3.33e-05	0.014	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	3.16e-05	0.0133	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCR4—sarcoma	2.81e-05	0.0118	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCR4—sarcoma	2.55e-05	0.0107	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TLE1—sarcoma	2.37e-05	0.00994	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFC—sarcoma	2e-05	0.00839	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	1.96e-05	0.00825	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCR4—sarcoma	1.88e-05	0.0079	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	1.79e-05	0.00751	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCR4—sarcoma	1.71e-05	0.00718	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	1.69e-05	0.0071	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FLT1—sarcoma	1.6e-05	0.00671	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TLE1—sarcoma	1.58e-05	0.00666	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PLCG1—sarcoma	1.57e-05	0.00659	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCR4—sarcoma	1.51e-05	0.00633	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ATF1—sarcoma	1.49e-05	0.00626	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	1.44e-05	0.00603	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CREB1—sarcoma	1.37e-05	0.00574	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFC—sarcoma	1.34e-05	0.00562	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF1R—sarcoma	1.17e-05	0.00491	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FOXO1—sarcoma	1.11e-05	0.00468	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IL2—sarcoma	1.11e-05	0.00468	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDGFRB—sarcoma	1.11e-05	0.00467	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDGFRA—sarcoma	1.09e-05	0.0046	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FLT1—sarcoma	1.07e-05	0.00449	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLCG1—sarcoma	1.05e-05	0.00441	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL2—sarcoma	1.01e-05	0.00425	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCR4—sarcoma	1.01e-05	0.00424	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ATF1—sarcoma	9.98e-06	0.00419	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KDR—sarcoma	9.21e-06	0.00387	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CREB1—sarcoma	9.15e-06	0.00385	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KIT—sarcoma	8.48e-06	0.00356	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—NRAS—sarcoma	8.48e-06	0.00356	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CREB1—sarcoma	8.08e-06	0.00339	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1R—sarcoma	7.83e-06	0.00329	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EGFR—sarcoma	7.73e-06	0.00325	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FOXO1—sarcoma	7.45e-06	0.00313	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IL2—sarcoma	7.45e-06	0.00313	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDGFRB—sarcoma	7.44e-06	0.00313	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDGFRA—sarcoma	7.32e-06	0.00308	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—KRAS—sarcoma	7.3e-06	0.00307	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL2—sarcoma	6.77e-06	0.00284	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MDM2—sarcoma	6.68e-06	0.00281	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HRAS—sarcoma	6.21e-06	0.00261	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KDR—sarcoma	6.17e-06	0.00259	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL2—sarcoma	5.97e-06	0.00251	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCND1—sarcoma	5.82e-06	0.00245	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JUN—sarcoma	5.81e-06	0.00244	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CTNNB1—sarcoma	5.76e-06	0.00242	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KIT—sarcoma	5.68e-06	0.00239	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—NRAS—sarcoma	5.68e-06	0.00239	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CREB1—sarcoma	5.41e-06	0.00227	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SRC—sarcoma	5.21e-06	0.00219	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EGFR—sarcoma	5.17e-06	0.00217	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—sarcoma	5.07e-06	0.00213	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NRAS—sarcoma	5.01e-06	0.00211	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KRAS—sarcoma	4.89e-06	0.00205	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MYC—sarcoma	4.67e-06	0.00196	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGFR—sarcoma	4.57e-06	0.00192	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MDM2—sarcoma	4.47e-06	0.00188	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KRAS—sarcoma	4.31e-06	0.00181	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HRAS—sarcoma	4.15e-06	0.00175	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL2—sarcoma	4e-06	0.00168	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCND1—sarcoma	3.9e-06	0.00164	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JUN—sarcoma	3.89e-06	0.00163	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CTNNB1—sarcoma	3.86e-06	0.00162	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—sarcoma	3.83e-06	0.00161	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HRAS—sarcoma	3.67e-06	0.00154	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SRC—sarcoma	3.49e-06	0.00147	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—sarcoma	3.4e-06	0.00143	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NRAS—sarcoma	3.36e-06	0.00141	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—sarcoma	3.13e-06	0.00131	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGFR—sarcoma	3.06e-06	0.00128	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KRAS—sarcoma	2.89e-06	0.00121	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—sarcoma	2.57e-06	0.00108	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HRAS—sarcoma	2.45e-06	0.00103	CbGpPWpGaD
